Fundraising FoxMedTech Venture Partners
Venture capitalMenlo Park · Seed–Series A · 29 people tracked
Also known as MTVP MANAGEMENT, LLC
Find your way into MedTech Venture Partners
Each arrow is one introduction. Sign up to fill in the first one.
Ask Brook Byers to introduce you to Jesse Gee
You →Brook · together at MedTech Venture Partners →Jesse
Ask Jamie Chen to introduce you to Radu Cautis
You →Jamie · together at MedTech Venture Partners →Radu
Ask Sam Okafor to introduce you to Thomas Glanzmann
You →Sam · together at MedTech Venture Partners →Thomas
- Peter Loescher1 person can intro you
- Javad Seyedzadeh1 person can intro you
- Christine Winoto1 person can intro you
Sign up to find every way you can get introduced to MedTech Venture Partners
- Your email: who you already know at MedTech Venture Partners, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MedTech Venture Partners team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
MedTech Venture Partners concentrates on funding and supporting medical device entrepreneurs. The team draws on collective operating experience across the conception, development, and launch of over 30 medical devices and diagnostics products, along with extensive global clinical and regulatory expertise. They have scaled early-stage device companies, operated larger ones, and been involved in buying and selling technologies, products, and companies. The firm believes this hands-on background gives it a strong understanding of device founders and enables it to help them succeed.
Source: firm website, verified Sep 29, 2026.
Team · 29 people
from the firm's website & public directories
What they invest in
from 3 of 3 portfolio companiesHealthtech ×3Biotech ×1Medical Devices ×1
HQs:United States×2
Investments · 3 tracked
founders shown can be your intro pathBy year:2026 · 12023 · 12019 · 13 dated
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalFemHealth VenturesGilde HealthcareMVM Life Science Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Frequently asked questions
- What stage does MedTech Venture Partners invest at?
- MedTech Venture Partners invests at the Seed, Series A stages.
- What sectors does MedTech Venture Partners focus on?
- MedTech Venture Partners focuses on Medical Devices.
- Where is MedTech Venture Partners located?
- MedTech Venture Partners is headquartered in Menlo Park, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blackbird is a venture capital firm that backs founders from the earliest stages, with a focus on ambitious technology startups across Australia and New Zealand.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.